Norris Medicines Share Price

BSE
NORRIS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Norris Medicines
Norris Medicines Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Norris Medicines Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
39.98% Fall from 52W High
-29
Dividend yield 1yr %
0

Norris Medicines shareholding Pattern

Promoter
34%
Domestic Institutions
0.1%
Public
65.9%
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%
Promoter
34%
Domestic Institutions
0.1%
Public
65.9%

Norris Medicines Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
16.90
10Day EMA
17.00
12Day EMA
17.00
20Day EMA
17.10
26Day EMA
17.30
50Day EMA
18.00
100Day EMA
18.60
200Day EMA
18.10
5Day SMA
16.80
10Day SMA
17.10
20Day SMA
16.80
30Day SMA
17.30
50Day SMA
18.20
100Day SMA
19.50
150Day SMA
19.40
200Day SMA
18.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
1898 Rs
2176 Rs
Week Rs
1826 Rs
2146 Rs
Month Rs
1111 Rs
1302 Rs
Resistance & Support
17.12
Pivot
Resistance
First Resistance
18.23
Second Resistance
19.82
Third Resistance
20.93
Support
First Support
15.53
Second support
14.42
Third Support
12.83
Relative Strength Index
44.75
Money Flow Index
45.61
MACD
-0.34
MACD Signal
-0.42
Average True Range
1.69
Average Directional Index
30.16
Rate of Change (21)
-4.31
Rate of Change (125)
-2.63

Norris Medicines Latest News

29 APR 2025 | Tuesday

Norris Medicines Ltd - 524414 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

04 APR 2025 | Friday

Norris Medicines Ltd - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

29 MAR 2025 | Saturday

Norris Medicines Ltd - 524414 - Closure of Trading Window

View More

Norris Medicines Company background

Founded in: 1990
Managing director: Vimal D Shah
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.91. The production unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995.In 2006, the Company launched Diabetic Cardiac products launched Dental product in 2007 launched New Molecule Tolperisone with Paracetamol tablet in 2012 in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet dry syrup. During the year 201314, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO GMP approved. At present, it has renovated the Sterile Injectable Plant and with this the plant is now as per international standards.
Read More

Norris Medicines FAQs

The Mutual Fund Shareholding in Norris Medicines was 0.01% at the end of 30/4/2025.

You can easily buy Norris Medicines shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Norris Medicines stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -